Mednet Logo

Do you offer a curative surgery (Whipple procedure) to patients with duodenal adenocarcinoma, with 2-5 liver metastases, and with near CR after 3-6 months of FOLFOX chemotherapy?

Is there a role for circulating tumor DNA in this setting?
3 Answers
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Rutgers Cancer Institute of New Jersey
Answered on

While Dr. @Dr. First Last correctly states that this is a rare situation and therefore a "data-free" zone, the answer may depend on how one perceives duodenal cancer: is it akin to colon cancer or more aligned with gastric or upper GI cancer? While small bowel and colon cancers exhibit several biolo...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Mayo Clinic
Answered on

Small bowel malignant tumors are uncommon. Estimated approximately 12,000 new cases and 2,000 deaths per year in the United States (compared to more than 150,000 new cases of colorectal cancer per year) and adenocarcinomas represent about 25-40% of the primary small bowel malignancies. Due to the un...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Stanford University School of Medicine
Answered on

I highly agree with this.

Because CRC can be curable even in the oligometastatic setting, we become accustomed to offering it. For example, partial hepatectomy to these patients (in combination c/ partial colectomy) to move forward with curative intent.

But even in CRC, these cases should be careful...

Join for free or sign in to see the full answer